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Abstract
Hepatic lipase (HL) gene expression was studied in rat ovaries. A transcript lacking exons 1 and 2 could be detected by reverse
transcription-polymerase chain reaction (RT-PCR) in the ovaries of mature cyclic females and of immature rats treated with
pregnant mare serum followed by human chorionic gonadotropin (hCG) to induce superovulation. By competitive RT-PCR the
HL transcript was quantified. Low levels of HL mRNA were detected in ovaries of mature cyclic females and of immature rats.
During superovulation HL mRNA was several fold higher than in mature cyclic rats and transiently increased to a maximum at
2 days after hCG treatment. Pulse-labelling of ovarian cells and ovarian slices with [35S]methionine followed by immunoprecipi-
tation with polyclonal anti-HL IgGs showed de novo synthesis of a 47 kDa HL-related protein. Expression of the protein was
transiently induced by gonadotropins with a peak at 2 days after hCG treatment. Induction of liver-type lipase activity occurred
only after HL mRNA and synthesis of the HL-related protein had returned to pre-stimulatory levels. We conclude that in rat
ovaries the HL gene is expressed into a variant mRNA and a 47 kDa protein. The expression of the HL gene in ovaries is
inducible and precedes the expression of the mature, enzymatically active liver-type lipase. Copyright © 1997 Elsevier Science
Ireland Ltd.
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1. Introduction
Ovaries and adrenals of rats and humans have been
shown to contain a lipase activity (liver- or l-type
lipase) similar to hepatic lipase (HL) normally present
in liver sinusoids [1–5]. Whereas the liver enzyme plays
a role in the uptake of circulating lipoproteins and its
components, the l-type lipase in the steroidogenic or-
gans is suggested to mediate the delivery of high-density
lipoprotein cholesterol required for hormone synthesis
[6]. In rat ovaries, the l-type lipase activity is mainly
localized in the corpora lutea, which are most active in
steroidogenesis [4,7] and is increased several-fold in
immature rats upon induction of superovulation [8].
The l-type lipase activity in the ovaries varies during
the oestrous cycle and lactation in parallel with proges-
terone and 20a-hydroxyprogesterone output [2,7,8].
The l-type lipase present in steroidogenic organs is
thought to originate from the liver since full-length HL
mRNA was not detected in adrenals and ovaries [9,10].
In this model, the lipase is secreted by the parenchymal
liver cells, and then transported through the circulation
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to the steroidogenic organs. Rat ovaries are indeed
shown to selectively sequester [125I]HL from the circula-
tion [9]. We recently found that the HL gene is tran-
scribed in rat ovaries as well as in human and rat
adrenals [11]. In rat adrenals, however, the mRNA
product markedly differed from that in liver [12]. In the
adrenal mRNA, the exons 1 and 2 of the HL gene are
replaced by a novel sequence, so that it no longer
encodes for the normal HL protein. Instead, a candi-
date translation product of about 45 kDa was identified
[12]. This prompted us to study HL gene expression in
rat ovaries. We show here that the HL gene products in
the ovaries resemble that found in adrenal glands.
Moreover, HL gene expression in ovaries is transiently
stimulated several-fold upon induction of superovula-
tion and was found to precede the acquisition of enzy-
matically active l-type lipase.
2. Materials and methods
2.1. Tissues
Locally bred Wistar rats were housed under con-
trolled conditions of temperature, humidity and light
(12 h light:12 h dark; light on at 07:00 a.m.), with free
access to tap water and to a standard pellet diet.
Animals were killed by decapitation under light diethyl
ether narcosis. Ovaries were dissected from mature
cyclic rats weighing 250–300 g. Alternatively, ovaries
were isolated from 25–30 days old female rats in which
superovulation was induced by a s.c. injection of 10 IU
pregnant mare serum (PMS) (Gestyl, Organon, Oss,
Netherlands) followed 2 days later with an injection of
10 IU human chorionic gonadotropin (hCG; Pregnyl,
Organon, Oss, Netherlands). The day of hCG injection
was designated as day 0. The dissected ovaries were
placed in ice-cold phosphate-buffered saline (PBS) and
the adherent fat tissue was rapidly trimmed off. Liver
and whole adrenals were dissected from young adult
males weighing 200–250 g. The tissues were either used
immediately, or frozen in liquid nitrogen and stored at
80°C.
2.2. RNA analysis
Total RNA was isolated from whole organs by the
method of Chomczynski and Sacchi [13]. RNA concen-
trations were determined by spectrophotometry at 260
nm [14]. The quality of the RNA preparations was
judged from the pattern of ribosomal RNA after gel-
electrophoresis [14]. HL mRNA was determined by a
single tube reverse transcription-polymerase chain reac-
tion (RT-PCR) starting from 1 mg of total RNA [12].
Random-primed cDNA was amplified for 30–35 cycles
using different HL-specific primers. HL-1 (5%-GTG
GGC ATC AAA CAG CCC-3%, nt 712–729; number-
ing according to the rat cDNA sequence [15] and HL-2
(5%-CAG ACA TTG GCC CAC ACT-3%, nt 1307–1289)
were used in quantitative PCR. The sense oligonucle-
otides HL-12 (5%-TGG CTT GCT AGA AAC CTG
G-3%, nt 297–315), HL-13 (5%-TGT CAT GAT CAT
CCA CGG G-3%, nt 267–285) and INT (5%-GCA TTG
TCC TTG AGC CTG AG-3, nt-112 to 93 according
to the sequence upstream of exon 3 in adrenal HL
mRNA [12]) were used in combination with the anti-
sense oligonucleotide HL-9 (5%-GGC ATC ATC TGG
AGA AAG GC-3%, nt 660–641) to determine the 5%-end
of the HL mRNA. Quantitation of HL mRNA was
done by competitive RT-PCR, in which 1 mg tissue
RNA was mixed with 0.5 mg yeast RNA (Pharmacia,
Uppsala, Sweden) containing increasing amounts of
competitor RNA prior to reverse transcription and
amplification [12]. The competitor RNA was obtained
by in vitro transcription of an HL cDNA clone in
pBluescript KS which had been modified by deletion
of an internal 80-bp Sau3A fragment (nt 1009–1088,
numbering according to [15]). The amount of target
RNA was determined from ethidium-bromide-stained
gels by taking (or extrapolating to) the amount of
internal competitor RNA that produced an equal signal
intensity. All RT-PCR experiments included no-tem-
plate and no-RT controls that remained negative.
2.3. Pulse-labelling with [ 35S]methionine
Pulse-labelling studies were performed either with
whole-ovary slices, or with ovarian cells isolated from
female rats 2 days after treatment with hCG. Freshly
dissected ovaries were roughly minced using a razor
blade. The resulting slices were incubated in 1 ml
methionine-free minimum essential medium, Eagle’s
modified (MEM) containing 25 U:ml heparin (Leo
Pharmaceuticals, Weesp, Netherlands) and 20% bovine
serum (dialysed and lipoprotein-free) at 37°C in a shak-
ing water bath under an atmosphere of 5% CO2:95%
O2. In some experiments, the tissue slices were first
incubated for 45 min at 37°C with 3 mg:ml of collage-
nase (type I, Sigma, St. Louis, USA); thereafter, intact
cells were collected by centrifugation (10 min, 100g,
20°C) through a cushion of 0.5% BSA in PBS [16]. The
cell pellet was resuspended in methionine-free MEM
and incubated in a final concentration of 1–2106
cells:ml as described above for the tissue slices. After 30
min incubation, 80 mCi of Tran35S-label (ICN, Cosa
Mesa, USA) was added and the pulse-labelling was
allowed to proceed for 2 h. The incubation was stopped
on ice, and the cells:tissue and cell-free media were
separated by centrifugation (10 000g, 20 s, 4°C). The
cell pellet was washed twice with ice-cold PBS and then
lysed for 45 min at 4°C in PBS containing 1% Triton
X-100, 1% sodium deoxycholate, 10 mM Hepes (pH
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7.4), 25 U:ml heparin, 1 mM L-methionine, 1 mM
EDTA, 10 mg:ml benzamidine, 10 U:ml Trasylol, and 1
mg:ml each of leupeptin, antipain, chymostatin and
pepstatin. After centrifugation (10 min, 10 000g,
4°C), the lysates were used for immunoprecipation.
2.4. Immunoprecipitation
Tissue and cell lysates were pre-cleared by incubation
for 2 h at 4°C with non-immune goat IgG immobilized
onto Sepharose-4B (Pharmacia, Uppsala, Sweden). Af-
ter removal of the beads, the lysates were incubated
overnight with polyclonal goat anti-rat HL IgGs cou-
pled to Sepharose-4B. Some immunoprecipitations were
carried out in the presence of an excess unlabelled,
partly purified rat hepatic lipase [17]. The beads were
collected by centrifugation and then washed with 1 ml
of, successively, PBS, 1 M NaCl in PBS, 0.2% Tween-
20 in PBS and PBS (all at 4°C). The final pellet was
resuspended in Laemmli sample buffer [18], heated for
5 min at 95°C and the beads were removed by centrifu-
gation. The released proteins were analyzed by SDS-
PAGE on a 10% polyacrylamide gel, followed by
fluorography using Amplify (Amersham, UK). The au-
toradiograms were scanned with the HP ScanJet II CX
densitometer, and the integrated optical density was
expressed in arbitrary units.
2.5. l-Type lipase assay
The ovaries were homogenized in 10 Vol. of ice-cold
PBS (pH 7.4) containing 5 U:ml of heparin and 1 mM
benzamidine. After centrifugation (10 000g, 2 min,
4°C), the post-nuclear supernatant was assayed for
triacylglycerol hydrolase activity at pH 8.5 in 0.6 M
NaCl using a gum-acacia stabilized glycerol
[3H]trioleate emulsion as substrate [3]. In immunoinhi-
bition assays, the supernatant was pre-incubated for 1 h
at 4°C with excess goat anti-rat HL IgGs immediately
before the lipase assay. HL activity is defined here as
the triglyceridase activity that was sensitive to im-
munoinhibition [17]. Enzyme activities were expressed
as mU (nmol of free fatty acids released per min).
3. Results
3.1. Effect of gonadotropins on HL mRNA in rat
o6aries
RT-PCR on total ovary RNA isolated from mature
cyclic rats and from immature superovulating rats using
the primers HL-1 and HL-2 yielded the expected 596-
bp product, whose identity with part of HL cDNA has
been confirmed by restriction mapping and internal
re-amplification [11]. In order to obtain UV-detectable
DNA bands, 5–10 extra cycles of amplification were
required with RNA from mature rats than from that of
superovulating animals, suggesting that the amount of
HL mRNA was higher in the gonadotropin-stimulated
ovaries. Quantitation of HL mRNA was done by com-
petitive RT-PCR using HL RNA that lacked an inter-
nal 80-nt fragment as competitor (Fig. 1). In five
independent ovaries from cyclic female rats, the amount
of HL mRNA ranged from 0.002 to 0.005 attomoles
per mg of total RNA. In the ovaries from superovulat-
ing rats, the amount of HL mRNA was at least ten-fold
higher at 0.05–0.4 attomoles per mg total RNA, de-
pending on the treatment with gonadotropins (see be-
low). Using the same assay, rat liver was shown to
contain 5–10 attomoles HL mRNA per mg total RNA.
Hence, the HL gene is expressed in rat ovaries to a level
two to three orders lower than in liver.
Although part of the HL gene transcript could be
detected by RT-PCR in ovaries, we were unable to
amplify the entire HL cDNA from ovary RNA, either
isolated from mature cyclic rats or from young super-
ovulating rats. For rat adrenals, we recently reported
that the HL gene is transcribed into a variant mRNA in
which exons 1 and 2 are replaced by a unique sequence
[12] representing part of intron 2 immediately upstream
of exon 3 (manuscript in preparation). To test whether
this also holds for the ovaries, RT- PCR was performed
using HL-9, a down-stream primer recognizing exon-5,
in combination with different upstream primers (Fig.
2). With HL-12, an exon-3 specific oligonucleotide, the
expected 481-bp product was obtained with RNA from
Fig. 1. Quantitation of HL mRNA by competitive RT-PCR. Compet-
itive RT-PCR was performed in total tissue RNA from rat liver (A),
ovaries from mature cyclic (B) and from immature superovulated rats
2 days treated with hCG (C). To 1 mg RNA the indicated amount of
competitor was added. Amplification was performed in 20 (liver), 30
(superovulated rats) or 35 cycles (cyclic rats). The arrowheads indi-
cate the lanes where intensities of both bands are identical.
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Fig. 2. Detection of the HL mRNA by RT-PCR in liver and steroidogenic tissues. The exon organization of the rat full-length HL cDNA and
the alternative 5%-end found in steroidogenic tissues is represented in (A). The arrows show the position and orientation of the oligonucleotides
used in RT-PCR. HL mRNA in ovary (O), adrenal (A) and liver (L) was detected by RT-PCR (B). A water control (w) was used. RNA was
reverse-transcribed and amplified as described in Materials and methods using the given upstream primer and HL-9 as a common downstream
primer. The resulting cDNA was amplified for 30 (liver and adrenal) or 40 (ovary) cycles.
stimulated ovaries as well as with adrenals and liver.
With HL-13, an exon-2 specific primer, the expected
511-bp band was observed with liver, but not with
ovaries or adrenals. Using INT, which anneals to the
unique 5%-end of the variant HL mRNA transcript
found in adrenals and liver [12], a 598-bp product was
obtained with ovaries, similar to the expected band seen
with adrenals and liver. The 598-bp amplimers from
ovaries and adrenals were identical, as determined by
direct sequencing (data not shown). We conclude there-
fore, that in rat ovaries the HL gene is transcribed
virtually only into the variant HL message also found
in adrenals.
3.2. De no6o synthesis of HL-related proteins
The de novo synthesis and secretion of HL-related
proteins was studied in freshly isolated ovarian cells
and in ovarian slices, by pulse-labelling with
[35S]methionine followed by immunoprecipitation with
polyclonal anti-HL IgGs. In ovarian cells no radiola-
belled protein was detected in the 55–60 kDa range
corresponding to mature HL synthesized and secreted
by rat liver (Fig. 3). Instead, four major 35S-labelled
protein bands with apparent Mw of 200, 67, 50 and 47
kDa were obtained. Even after 2 h pulse-labelling, these
bands were not detectable in the cell-free medium,
indicating that these proteins remained intracellularly.
These bands co-migrated with the proteins immunopre-
cipitated from pulse-labelled rat adrenocortical cells
(data not shown). In contrast to the 67 and 50 kDa
band, immunoprecipitation of the 200 kDa and 47 kDa
bands was markedly suppressed by the inclusion of
excess cold HL partially purified from rat liver per-
fusates. Qualitatively similar results were obtained us-
ing a mixture of five different monoclonal anti-HL
antibodies. In all conditions tested thus far, the 35S-ra-
dioactivity of the 200 and 47 kDa bands varied in
parallel.
3.3. Effect of gonadotropins on HL gene expression
The expression of the variant HL mRNA in rat
ovaries was compared with that of the 47 kDa HL-re-
lated protein at different times after hCG treatment. As
shown in Fig. 4, the amount of the variant HL mRNA
was increased approximately four-fold 2 days after
treatment with hCG. Six days after treatment with hCG
the HL mRNA had decreased again to pre-stimulatory
levels. The de novo synthesis of the 200 and 47 kDa
proteins was also transiently increased during super-
ovulation (Fig. 4). After 2 days of treatment with hCG
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Fig. 3. Pulse-labelling of ovarian cells with [35S]methionine. Freshly
isolated ovarian cells from 2 days treated females with hCG were
pulse-labelled for 1 or 2 h. Cell lysates (c) and cell-free medium (m)
were immunoprecipitated with polyclonal anti-HL IgGs coupled to
Sepharose-4B beads in presence ( ) and in absence ( ) of an excess
of unlabelled purified HL. The adsorbed proteins were analyzed by
SDS-PAGE on a 10% gel followed by fluorography. The position of
the molecular weight standards is given in kDa.
days after hCG treatment. Thus, the expression pattern
of the variant HL mRNA and 35S incorporation into
the 47 kDa protein was similar. The effect of hCG on
the l-type lipase activity in the stimulated ovaries
showed a strikingly different pattern (Fig. 4). The en-
zyme activity began to increase after 2 days of treat-
ment with hCG and continued to increase thereafter.
On a mg protein basis, the l-type lipase activity present
in the ovaries was maximal after 4 days of hCG treat-
ment and remained high at least until 6 days after hCG
injection.
4. Discussion
We show here that the rat HL gene is transcribed
into a variant mRNA, not only in adrenals, but also in
ovaries. This transcript appears to be the major, if not
only, HL gene product in these steroidogenic organs. In
the liver, it is also present but as a minor component
compared to the full-length message encoding HL [12].
As discussed before, this second HL gene product may
represent an alternatively spliced form, or may be the
product of an alternative transcription start site in the
intron preceding exon-3. Since this variant mRNA
lacks the first two coding exons of the full-length form
found exclusively in liver, its possible translation
product would be considerably shorter than the 58 kDa
HL protein. Moreover, the protein product would
probably remain intracellularly because of the absence
of a signal peptide. Whether such a protein product
would be catalytically active is presently unknown. It is
unlikely, however, that such a protein is responsible for
the l-type lipase activity found in the steroidogenic
organs, since (i) the abundance of HL gene transcripts
in adrenals and ovaries is 10- to 100-fold less than in
liver, despite the presence of a similar lipase activity per
mg protein [8] and (ii) the pattern of expression of the
l-type lipase activity in ovaries during superovulation
differs markedly from that of HL mRNA. This study
therefore strengthens the hypothesis that the l-type
lipase activity found in rat ovaries originates from liver
[9,10]. Hepatic lipase injected into the circulation is
selectively sequestered by the ovaries [9]. During PMS:
hCG-induced neovascularization and differentiation of
the ovary the hepatic lipase appeared specifically in the
blood vessels of the theca interna of follicles, corpora
lutea and interstitial tissue [19]. How the lipase is
transported from the liver to the steroidogenic organs
and how the protein is specifically sequestered into
these organs remains to be determined.
Two immunoreactive proteins of 47 and 200 kDa
were found in ovaries as well as in adrenals (data not
shown) after pulse-labelling and immunoprecipitation.
The 47 kDa protein would be an obvious candidate as
a translation product of the variant HL mRNA. This is
the 35S-incorporation into both HL-related proteins
increased several-fold. Thereafter, the 35S-incorporation
decreased again and returned to pre-stimulatory levels 6
Fig. 4. Transient HL gene expression in immature rat ovaries induced
by hCG. Female rats (25–30 days old) were treated with 10 IU PMS
followed 2 days later by 10 IU hCG (day 0). Of each animal, one
ovary was used for RNA measurement, whereas the other ovary was
used for protein measurements. Quantitation of HL mRNA (hatched
bars) was carried out by RT-PCR using primers HL-1 and HL-2;
data are given as % of results of day 0; 0.07590.01 amoles:mg;
(mean9SE, n3). Ovarian tissue slices were pulse-labelled with
[35S]methionine for 2 h followed by immunoprecipitation and SDS-
PAGE. The gel was then exposed to a film and the 47 kDa protein
band was scanned. Data (open bars) are expressed in arbitrary units
of relative blackness given as % of day 0, and are representative for
2 independent experiments. l-Type lipase activity () was measured in
tissue homogenates and given as the lipase activity sensitive to
polyclonal anti-HL antibodies (mean9SE, n3).
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strongly supported by the resemblance in the transient
expression pattern of both the HL-related protein and
the HL mRNA upon induction of superovulation. Since
the unique 5%-end of the variant HL mRNA contains
multiple translation stop codons and lacks potential
start codons, translation must have started at the first
in-frame AUG, which occurs in exon 4 upstream of the
catalytic triad [12]. Hence, this protein may possess
esterase activity towards some ester substrates. The 200
kDa band always varied in parallel with the 47 kDa in
the immunoprecipitates, suggesting that their expression
is somehow related. Whether the high Mw protein
represents aggregates of the 47 kDa form, or a 47 kDa
protein covalently linked to another protein, is presently
under investigation in our laboratory.
The finding that the HL gene is transcribed into a
variant mRNA, and possibly is translated into a 47 kDa
HL-related protein, exclusively in the steroid-producing
organs, suggests a role for this gene product in choles-
terol metabolism. Induction of follicle development and
corpora lutea formation by treatment with PMS and
hCG, results in a marked increase in steroid hormone
production by the ovaries and hence in a demand for
cholesterol [7]. Cholesterol needed for steroid produc-
tion is either mobilized from endogenous cholesterol
ester stores, synthesized de novo, or delivered to the
ovaries by circulating high- and low-density lipoprotein
(HDL and LDL), processes mediated by the l-type lipase
and the LDL receptor, respectively [20]. The transient
expression of the HL gene in ovaries of superovulating
rats observed here (Fig. 4) coincides with the fall in
intracellular cholesterol esters and parallels the transient
increase in cholesterol de novo synthesis [21]. Taken
together, these data suggest a role, either structural or
catalytical, for the variant HL gene product in the de
novo synthesis and:or mobilization of endogenous
cholesterol in these organs. At the time that the endoge-
nous cholesterol becomes limited, the extracelluarly lo-
calized l-type lipase is increased. This enzyme facilitates
the influx of HDL-cholesterol in a process possibly
involving the recently identified SR-BI receptor [22].
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